Xueqing Tang

1.0k citations
47 papers · 644 indexed · h-index 13
Topics
Renal Diseases and Glomerulopathies (10 papers)Autoimmune Bullous Skin Diseases (6 papers)Reservoir Engineering and Simulation Methods (6 papers)
Journals
Advanced MaterialsSHILAP Revista de lepidopterologíaPLoS ONE

In The Last Decade

Xueqing Tang

43 papers receiving 634 citations

Peers

Xueqing Tang
Comparison fields: 5 of 104
  • Rheumatology 202
  • Nephrology 201
  • Molecular Biology 195
  • Immunology 109
  • Cancer Research 90
Replace Hong Ren with:
Hong Ren China
Jeong Hae Kie South Korea
Le‐Ting Zhou China
Yueqiang Li China
Samuel Mon-Wei Yu United States
Koei Yamada Japan
Hagen Staude Germany
Shinya Nagasaka Japan
Christopher M. Ferguson United States
Denise D’Andrea United States
Xueqing Tang relative to Hong Ren China Hong Ren's profile →
Citations per field
00.5×1.5×2.1×
Hong Ren · 1×
Citations per year

Countries citing papers authored by Xueqing Tang

Since Specialization
Citations

This map shows the geographic impact of Xueqing Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueqing Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueqing Tang more than expected).

Fields of papers citing papers by Xueqing Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueqing Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueqing Tang. The network helps show where Xueqing Tang may publish in the future.

Co-authorship network of co-authors of Xueqing Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Xueqing Tang. A scholar is included among the top collaborators of Xueqing Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueqing Tang. Xueqing Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 2
5 2
6 3
7 6
8 1
9 11
10 9
11 12
12 32
13 13
14 7
15 7
16 23
17 15
18 18
19 142
20 11

About Xueqing Tang

Xueqing Tang is a scholar working on Nephrology, Geriatrics and Gerontology and Complementary and alternative medicine, having authored 47 papers that have together received 644 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (10 papers), Autoimmune Bullous Skin Diseases (6 papers) and Reservoir Engineering and Simulation Methods (6 papers). The work is most often cited by research in Nephrology (201 citations), Rheumatology (202 citations) and Hepatology (59 citations). Xueqing Tang has collaborated with scholars based in China, Australia and United Kingdom. Frequent co-authors include Xueqing Yu, Qinghua Liu, Huajun Liu, Wenbin Liu, Lin Yuan, Zhibin Li, Lin Chen, Yiru Wang, Zhange Li and Haiyang Zhang. Their work appears in journals such as Advanced Materials, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026